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We present a case of a patient who developed a metachronous splenic metastasis from renal clear cell
carcinoma, for which he has undergone a left nephrectomy 14 years earlier. During his routine follow up
a CT scan showed a splenic mass which was considered an isolated metastasis possibly originating from
the renal cancer. A splenectomy was performed and histopatological examination of the spleen
conﬁrmed the presence of clear cell carcinoma with inﬁltration of the capsule. Splenic metastases are
uncommon and from the reported literature we understand that splenic metastasis from renal cell
carcinoma is extremely rare. The optimal treatment seems to be splenectomy with a good long term
outcome. With this report the authors would like to discuss the possibility that it could be a case of local
recurrence rather than a real metastasis. A revision of previous reports in the literature is performed too.
Published by Elsevier Ltd on behalf of Surgical Associates Ltd.1. Introduction
Splenic metastasis is an uncommon event, mostly deriving from
pulmonary, ORL, colorectum or ovarian tumors.1 They are clinically
silent and often discovered during the autopsy or with other distant
metastases.2 Splenic metastasis from renal cell carcinoma (RCC) is
rare and, to our best knowledge, up to now only few cases have
been reported in the literature.3e8 On the other hand, the natural
history of renal carcinoma is well known and not surprisingly such
cancer may recur locally after decade.9,10
This report wants to add to literature one more case of splenic
metastasis from renal cell carcinoma; additionally, we hereby
present a brief review of previous cases with a discussion if it
should be considered metastasis or local recurrence.2. Clinical case
A 68 years old Caucasian male, in good general conditions,
underwent left nephrectomy in 1994 for RCC (pT2, pV0, pN0; stage
II). Postoperative course was uneventful and no adjuvant therapy
was given. No signs of tumor recurrence were detected during
follow up with annual abdominal ultrasonography (US).
Fourteen years after the operation, a routine cancer screening
with US revealed a mass in the spleen of about 6 cm of diameter. A
total body CT scan conﬁrmed the presence of the lesion which was: þ39 06 97251367.
Ltd on behalf of Surgical Associatendowed in the hilum of the spleen (Fig. 1). Based on these radio-
logical ﬁndings, the splenic mass was diagnosed as a suspicious
metastatic lesion. No other lesions were detected.
PET-CT total body did not reveal lesions with increased meta-
bolic activity. Blood biochemistry and tumor markers were normal.
During the follow up in the next month the abdominal US and
CT scan showed a slight increasing of the mass size. Therefore, the
patient was admitted to our surgical department for open
splenectomy.
Surgery was performed by median laparotomic access without
any complication. Intraoperatively the spleen was tightly adherent
to the surrounding tissue, above all on its caudal side close to the
renal fossa. Splenectomywas performedwithout any complication;
partial removal of the tissue adherent to the surrounding the caudal
side of the spleenwas performed too and perioperative histology of
it resulted free from malignancy.
The patient recovered uneventfully and was discharged six days
after surgery. He received pneumococcal, meningococcal and H.
inﬂuenzae vaccine and underwent adjuvant chemotherapy with
sunitinib malate.
Hystopathological examination of the specimen conﬁrmed the
presence of a splenic mass of 7 cm in diameter, occupying the
hilium; additionally is described a partial inﬁltration of the caudate
capsule with no evidence of neoplastic cells in the resected tissue
surrounding it; necrotic tissue and multiple abscesses were
described too (Fig. 2).
Microscopy revealed the presence of RCC tissue with typically
cytokeratin (AE1/AE3, CK8, 18)/EMA/vimentin/CD10/N-cadherin
positive.es Ltd.
Table 1
Literature review of RCC splenic metastasis.
Author Patient age/
sex
Metastasizing
time
Therapy Outcome
Strum3 55/M 22 years Splenectomy 6 months, died
Murao4 72/M 10 years Splenectomy 1 year, alive
Pal5 54/F Simultaneous Splenectomy Unknown
Suzuki6 43/M 7 years Splenectomy 9 years, alive
Tastuta7 69/M 1 year and 10
months
Splenectomy 5 years 7 months,
alive
Mc Gregor8 65/M Simultaneous Splenectomy Unknown
Present case 68/M 14 years Splenectomy 1 year 3 months,
alive
Fig. 1. CT scan showing the mass in the hilum of the spleen (arrow).
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and CT scans at six and 12 months from surgery. 15 months after,
the patient is doing well with no signs of tumor recurrence.3. Discussion
Excluding haematological diseases, primary and metastatic
tumors to the spleen are uncommon. Anatomically the sharp angle
of the splenic artery with the celiac axis and rhythmic contraction
by the sinusoidal splenic architecture are limiting factors for
metastases.11 Physiological actions of the spleen, phagocytosis and
immunological antineoplastic action may also inhibit
metastasis.12,13
About 30% of the patients with renal cell carcinoma already have
distant metastasis at the time of diagnosis and the most common
sites are the lungs, bone, liver, lymph nodes, adrenal glands and
brain.11 In these cases adjuvant therapy is effective in only about
10% of patients.13 The prognosis if the metastases are multiple is
unfavourable, while if it is isolated the surgical resection of it is theFig. 2. Histology of the specimen showing clear cell from renal carcinoma (arrow).best treatment. If a complete resection of the metastasis is achieved
the prognosis is favourable.13
Splenic metastasis from RCC in extremely rare and up to now
only six cases has been described in the available literature3e8
(Table 1); one of them associated with pulmonary metastasis.7
The mean onset time, considering also the present case report, is
almost 8 years ranging from 0 to 22 years. The present case is the
second one with the longest onset time. Generally metastases are
discovered during the follow up with US and CT scan. PET scan
demonstrates modest accuracy in the diagnostic imaging evalua-
tion of patients with suspected or known metastatic clear RCC
because of its low index of glucidic intake. Therefore a negative
study, as in our case, may not exclude disease.14
Whereas locally recurrent disease from renal cell carcinoma
following nephrectomy is not so exceptional with an incidence
ranging from 2% to 4%.9,10,15,16 Several articles reported their
experience with the management of recurrence of renal fossa and
its mean onset time ranges from 1 to 6 years and it can be localized
in different tissues (lymph node tissue, retroperitoneal soft tissue
and adrenal gland).9,10,15,16 This event can be a real challenge for the
surgeon and oncologist as no standard therapeutic guidelines are
reported and the effect of aggressive surgical management of it
remains controversial; however also in this case is strongly rec-
ommended, when it is possible, a complete resection of the
recurrence with free margin, considering it the only deﬁnitive
therapy. However, patients who underwent surgical resection for
local recurrence had an improved 5-year survival rate of almost
50%.10,15,16
Considering the present case, the primary tumor location on left
side, the large onset time (14 years) and overall the fact that the
splenic capsule was not intact and the absence of other metastases
after so many years, raise the hypothesis of the possibility of a case
of local recurrence rather than a real metastasis. Up to now in the
literature no other clinical report has been published about local
recurrence of RCC into the spleen.
Although in both cases the recommended deﬁnitive treatment
is the surgery, in the literature we already have not enough infor-
mation to say in which case the prognosis would be better. More-
over, if it is considered a local recurrence, it is still controversial the
beneﬁt of adjuvant therapy when a complete resection of it has
been achieved with free margin, as in our case.4. Conclusions
Only few cases of splenic metastasis from renal cell carcinoma
have been reported.3e8 The case described here revived the ques-
tion of whether differentiate metastasis from local recurrence;
however in both cases the optimal treatment of it is the complete
surgical resection that results in an important prolonged survival.
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